Lymphadenopathy diagnostic criteria: Difference between revisions
| Line 20: | Line 20: | ||
:*No associated risk factors | :*No associated risk factors | ||
:*Palpable and painful enlargement | :*Palpable and painful enlargement | ||
<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref> | <ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref><ref name="pmid9803196">{{cite journal |vauthors=Ferrer R |title=Lymphadenopathy: differential diagnosis and evaluation |journal=Am Fam Physician |volume=58 |issue=6 |pages=1313–20 |date=October 1998 |pmid=9803196 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Revision as of 19:52, 4 February 2021
|
Lymphadenopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Lymphadenopathy diagnostic criteria On the Web |
|
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria |
|
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]Delband Yekta Moazami, M.D.[3]
Overview
Diagnostic criteria for malignant lymphadenopathy may include: the size of node more than 2 cm, a node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever, and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy may include: node smaller than 1 cm, a node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement.
Diagnostic Criteria
Malignant Lymphadenopathy
- Node > 2 cm
- Node that is draining, hard, or fixed to underlying tissue
- Atypical location (e.g. supraclavicular node)
- Risk factors (e.g. HIV or TB)
- Fever and/or weight loss
- Splenomegaly
Benign Lymphadenopathy
- Node < 1 cm
- Node that is mobile, soft-or tender, and is not fixed to underlying tissue
- Common location (e.g. supraclavicular node)
- No associated risk factors
- Palpable and painful enlargement
References
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Ferrer R (October 1998). "Lymphadenopathy: differential diagnosis and evaluation". Am Fam Physician. 58 (6): 1313–20. PMID 9803196.